Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yellin

Showing results (551-560 of 625) with videos related to

Pageof 63
Sort By:
Archives of Internal Medicine|June 13, 1998
Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Program on the Surgical Control of the HyperlipidemiasH Buchwald, R L Varco, J R Boen, et al.
Nature Medicine|April 10, 2019
Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccinationLinda Hammerich, Thomas U Marron, Ranjan Upadhyay, et al.
Drugs|March 20, 1998
Guidelines for the treatment of acidaemia with THAMG G Nahas, K M Sutin, C Fermon, et al.
Annals of Hematology|October 19, 2013
A phase 1/2 study of oral panobinostat combined with melphalan for patients with relapsed or refractory multiple myelomaJames R Berenson, James D Hilger, Ori Yellin, et al.
Nature Communications|November 23, 2022
Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunityJudit Svensson-Arvelund, Sara Cuadrado-Castano, Gvantsa Pantsulaia, et al.
Nature Communications|December 13, 2025
Human monoclonal antibodies that target clade 2.3.4.4b H5N1 hemagglutininGarazi Peña Alzua, André Nicolás León, Temima Yellin, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 27, 2006
Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanomaAjay V Maker, James C Yang, Richard M Sherry, et al.
British Journal of Haematology|September 29, 2011
A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patientsJames R Berenson, Ori Yellin, Chien-Shing Chen, et al.
Bone Marrow Transplantation|April 28, 2015
Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteersN Anandasabapathy, G Breton, A Hurley, et al.
Annals of Surgical Oncology|November 12, 2005
Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II studyAjay V Maker, Giao Q Phan, Peter Attia, et al.
Pageof 63

Showing results (551-560 of 625) with videos related to

Sort By:
Pageof 63
Archives of Internal Medicine|June 13, 1998
Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Program on the Surgical Control of the HyperlipidemiasH Buchwald, R L Varco, J R Boen, et al.
Nature Medicine|April 10, 2019
Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccinationLinda Hammerich, Thomas U Marron, Ranjan Upadhyay, et al.
Drugs|March 20, 1998
Guidelines for the treatment of acidaemia with THAMG G Nahas, K M Sutin, C Fermon, et al.
Annals of Hematology|October 19, 2013
A phase 1/2 study of oral panobinostat combined with melphalan for patients with relapsed or refractory multiple myelomaJames R Berenson, James D Hilger, Ori Yellin, et al.
Nature Communications|November 23, 2022
Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunityJudit Svensson-Arvelund, Sara Cuadrado-Castano, Gvantsa Pantsulaia, et al.
Nature Communications|December 13, 2025
Human monoclonal antibodies that target clade 2.3.4.4b H5N1 hemagglutininGarazi Peña Alzua, André Nicolás León, Temima Yellin, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 27, 2006
Intrapatient dose escalation of anti-CTLA-4 antibody in patients with metastatic melanomaAjay V Maker, James C Yang, Richard M Sherry, et al.
British Journal of Haematology|September 29, 2011
A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patientsJames R Berenson, Ori Yellin, Chien-Shing Chen, et al.
Bone Marrow Transplantation|April 28, 2015
Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteersN Anandasabapathy, G Breton, A Hurley, et al.
Annals of Surgical Oncology|November 12, 2005
Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: a phase I/II studyAjay V Maker, Giao Q Phan, Peter Attia, et al.
Pageof 63